Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ABO	"A3GALNT, A3GALT1"	ENSG00000175164	"ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase"		9	133250401-133275219	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"intestine: 28.2"	"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 56.2;Collecting duct cells: 45.4;Enterocytes: 68.1;Mucus-secreting cells: 54.8;Paneth cells: 49.5;Undifferentiated cells: 61.3"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	8	"basophil: 2.1;eosinophil: 3.0;naive B-cell: 2.2"	"Group enriched"	"Detected in many"	8	"B-cells: 2.2;granulocytes: 3.0"	"Group enriched"	"Detected in some"	6	"K-562: 20.4;RT4: 8.0"	"Not detected"	"Not detected"												"Secreted to blood"	NA	NA						"unprognostic (2.78e-3)"	"unprognostic (2.56e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-2)"	"unprognostic (8.51e-2)"	"unprognostic (9.30e-3)"	"unprognostic (7.23e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.04e-2)"	1.6	1.0	0.1	5.8	0.1	0.3	0.4	0.0	0.6	1.0	15.0	0.0	2.3	1.7	1.6	0.8	3.0	0.3	7.6	0.3	0.0		10.7	0.3	3.6	0.3	0.0	0.0	3.2	2.6	0.3	0.0	0.3	0.2	1.5	2.4	1.0	2.2	0.3	1.4	0.3	28.2	0.6	0.0	0.3	0.3	2.0	0.0	0.0	10.1	4.2	5.8	1.0	1.4	2.2	0.1	3.0	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	3.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	2.2	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.2											29.8	22.2	0.5	3.6	0.0	0.0	2.8	17.8	56.2	27.3	45.4	0.0	0.7	0.0	3.7	3.3	6.8	68.1	0.0	0.3	0.2	0.8	6.5	0.0	0.0	0.2	0.0	24.6	3.1	0.6	6.7	14.1	0.3	0.0	1.0	54.8	0.0	8.2	49.5	6.3	19.5	0.1	6.5	0.6	0.5	1.5	0.0	0.6	0.0	61.3	15.2
B3GALT1	beta3Gal-T1	ENSG00000172318	"Beta-1,3-galactosyltransferase 1"	Q9Y5Z6	2	167868948-167874041	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 2.4;brain: 5.1;intestine: 5.8;skeletal muscle: 7.1"	"Cell type enhanced"	"Detected in some"	9	"Enterocytes: 3.1;Mucus-secreting cells: 4.2;Undifferentiated cells: 5.2"	"Cancer enhanced"	"Detected in some"		"glioma: 2.2"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	8	"AN3-CA: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.98e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.23e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.94e-2)"	"unprognostic (8.72e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.30e-3)"	"unprognostic (8.34e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.79e-1)"	0.1	0.6	0.5	0.0	1.6	0.0	0.3	0.9	5.1	0.2	5.6			0.0	0.2	0.3	0.0	0.8	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.3		0.1	0.2	0.0	0.8	0.0		0.1	5.8		0.1	0.9	7.1	0.0	0.1	0.0	0.1	0.0	0.0	0.5			0.1		0.0	0.0	0.1	1.4	0.8	2.0	0.5	1.0	2.4	0.4	0.0	0.0	2.2	28.6	0.2	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	1.1	0.1	0.0	0.0	0.0	0.0	3.7	0.0	1.0	0.0	0.1	0.0	0.4	0.0	1.9	0.3	0.0	0.0	0.5	1.4	0.0	0.0	0.0	0.2	0.1	0.3	0.3	0.0	0.6	0.0	0.5	0.0	2.6	2.0	0.5	0.3	0.6	0.3	0.7	1.1	0.7	0.7	0.2	1.4	2.4	1.3	1.5	1.0	0.3	0.8	0.6	0.4											0.0	2.2	0.0	0.0	0.1	2.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	3.1	0.0	0.2	0.0	0.2	0.1	1.1	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.6	0.0	1.7	0.0	4.2	1.9	0.0	0.0	1.4	0.2	1.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	5.2	0.0
B3GALT2	beta3Gal-T2	ENSG00000162630	"Beta-1,3-galactosyltransferase 2"	O43825	1	193179045-193186654	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 32.9;gallbladder: 19.0;heart muscle: 25.1"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 47.7;Cardiomyocytes: 27.8;Cholangiocytes: 15.3;Leydig cells: 29.4;Peritubular cells: 19.8"	"Cancer enhanced"	"Detected in some"		"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"MAIT T-cell: 11.9"	"Lineage enriched"	"Detected in single"	57	"T-cells: 11.9"	"Group enriched"	"Detected in some"	4	"AF22: 16.4;ASC TERT1: 7.5;LHCN-M2: 11.1;WM-115: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078659			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA078659: AB_2686887"	"unprognostic (1.83e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.34e-3)"	"unprognostic (2.43e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.14e-4)"	"unprognostic (4.41e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.56e-3)"	0.7	2.0	11.3	1.3	8.9	0.7	0.9	1.4	32.9	0.8	1.7	1.2	0.9	1.6	0.6	1.8	1.2	0.7	19.0	25.1	10.1	7.9	1.7	0.8	2.6	0.7	5.7	19.1	13.8	0.8	0.4	0.9	0.9	5.0	6.5	2.0	0.3	0.5	7.1	0.6	0.7	4.1	0.8	6.5	1.4	2.1	1.4	4.7	0.0	1.8	0.0	1.6	2.0	0.7	0.0	0.2	0.1	0.0	0.0	11.9	0.3	0.0	0.0	16.4	0.0	0.4	7.5	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	1.4	1.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.2	0.0	11.9	0.0	2.7	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	2.3	0.3	11.3	8.9	1.4	32.9	10.1	7.9	5.7	19.1	5.0	4.7	0.0	0.3	0.0	0.0	0.2	47.7	27.8	15.3	4.0	0.0	1.8	3.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.3	2.3	0.0	0.2	7.9	2.9	1.3	0.3	0.0	29.4	0.1	0.0	0.0	0.3	1.7	0.4	0.0	19.8	0.0	5.8	0.0	0.4	0.0	0.0	0.3	0.0	5.1	0.4	0.0
B3GALT5	"B3GalT-V, B3T5, beta3Gal-T5, GLCT5"	ENSG00000183778	"Beta-1,3-galactosyltransferase 5"	Q9Y2C3	21	39556442-39673137	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.8;intestine: 27.1;lymphoid tissue: 14.8"	"Group enriched"	"Detected in many"	5	"Enterocytes: 85.3;Intestinal endocrine cells: 27.7;Mucus-secreting cells: 45.4;Paneth cells: 85.2;Undifferentiated cells: 35.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"basal ganglia: 15.8"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 18.6;RPTEC TERT1: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054092, HPA054684"	Approved				"Intracellular and membrane"	NA	NA					"HPA054092: AB_2682375, HPA054684: AB_2682573"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (6.36e-4)"	"unprognostic (9.23e-2)"	"unprognostic (4.62e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (7.86e-3)"	"unprognostic (1.67e-1)"	"unprognostic (6.09e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.55e-3)"	0.1	0.3	0.5	3.1	15.8	0.1	1.8	0.3	1.5	3.0	16.2	0.6	0.0	19.4	1.4	1.6	2.3	1.0	12.9	0.2	1.3	1.5	0.6	0.3	0.2	0.1	0.7	0.1	0.7	6.2	0.1	7.9	0.7	2.2	1.0	27.1	2.2	5.5	0.1	0.2	1.1	23.4	0.7	2.0	0.2	3.8	0.6	3.6	1.8	1.1	0.8	14.8	1.1	5.9	0.2	0.2	1.0	0.2	0.3	0.2	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	18.6	0.0	0.2	0.1	1.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	5.0	0.1	0.5	0.0	2.1	0.1	22.0	1.4	3.7	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.6	0.1	0.8	0.0	0.0	0.0	1.0	0.0	0.3	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.0	0.3	0.0	0.2	0.0	0.0	0.5	15.8	0.3	1.5	1.3	1.5	0.7	0.1	2.2	3.6	0.0	0.0	0.0	0.2	0.0	6.7	1.7	10.2	1.4	7.9	5.2	0.0	0.0	0.0	6.5	0.3	0.0	85.3	0.0	4.1	0.0	0.0	0.4	4.6	0.0	0.0	0.0	27.7	0.0	0.0	0.6	0.6	0.0	0.0	0.0	45.4	1.4	6.0	85.2	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	35.9	6.7
B3GNT2	"B3GN-T1, B3GN-T2, B3GNT-2, B3GNT1, BETA3GNT"	ENSG00000170340	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2"	Q9NY97	2	62196113-62224731	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 43.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005997	Approved		Approved	Vesicles		NA	NA		43000000	Vesicles		"HPA005997: AB_1845234"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.63e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.25e-1)"	18.9	14.3	8.6	10.8	23.0	41.6	17.5	3.1	14.1	18.4	17.9	7.4	5.6	17.9	19.8	8.0	24.5	8.7	18.1	20.9	7.6	11.5	24.4	14.2	23.9	13.9	9.7	7.1	9.0	43.2	5.4	25.9	22.8	9.5	7.5	16.3	14.4	17.2	6.0	5.2	13.0	21.7	16.3	7.6	14.6	12.0	7.0	10.6	27.0	15.6	8.5	18.5	11.8	14.7	8.4	6.8	28.3	5.6	20.3	19.3	8.2	7.8	5.4	8.2	3.6	9.0	4.1	23.7	7.6	8.5	6.1	8.2	11.1	12.6	8.5	7.0	7.1	8.6	7.5	5.2	6.4	10.6	17.6	4.2	20.8	2.6	6.5	6.8	12.4	9.4	4.9	12.1	11.7	4.2	4.3	9.1	5.9	11.3	5.3	7.3	5.9	23.6	18.6	7.8	14.2	2.2	43.4	5.7	4.6	11.6	7.7	8.0	5.9	5.4	11.7	8.7	13.8	3.3	14.7	10.3	7.4	6.5	12.5	7.5	15.1	5.3	36.5	5.8	21.6	7.1	7.2	4.5	28.3	11.0	4.4	15.6	7.6	8.2	19.3	5.5	8.4	9.9	14.4	11.3	20.3	5.6	6.8	13.2	8.2	8.6	23.0	3.1	14.1	7.6	11.5	9.7	7.1	9.5	10.6	59.6	9.8	25.1	27.0	63.4	16.0	8.7	17.8	5.3	3.4	17.4	0.0	31.1	19.9	20.8	0.1	21.0	17.3	46.7	50.7	30.1	35.3	23.6	3.5	15.5	51.9	0.0	9.1	37.4	22.7	0.2	2.3	20.4	33.7	24.4	19.1	8.1	37.8	21.8	2.1	18.9	2.4	64.7	52.3	0.2	1.5	56.7	54.6	17.5	11.9	34.6
B3GNT3	"B3GN-T3, B3GNT-3, beta3Gn-T3, HP10328, TMEM3"	ENSG00000179913	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3"	Q9Y2A9	19	17794828-17813082	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 69.9;intestine: 61.6;placenta: 56.0"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 53.5;Cytotrophoblasts: 51.9;Enterocytes: 58.5;Mucus-secreting cells: 40.2;Paneth cells: 42.5;Syncytiotrophoblasts: 57.1;Urothelial cells: 43.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"memory CD4 T-cell: 2.7;memory CD8 T-cell: 1.1;naive CD4 T-cell: 3.2"	"Lineage enriched"	"Detected in single"	32	"T-cells: 3.2"	"Cell line enhanced"	"Detected in some"		"A-431: 16.5;BEWO: 16.3;CAPAN-2: 44.2;OE19: 40.5;RT4: 15.8;SK-BR-3: 15.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA024298	Enhanced				"Intracellular and membrane"	NA	NA					"HPA024298: AB_1845236"	"unprognostic (1.10e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.84e-3)"		"unprognostic (1.10e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (3.26e-1)"	"unprognostic (4.64e-2)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.44e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.57e-2)"	0.4	0.2	0.2	8.7	0.3	0.0	1.8	0.2	0.3	3.5	25.3	0.0	12.0	16.6	0.4	1.2	15.1	0.6	69.9	0.5	0.2	0.3	11.4	2.5	1.0	1.2	0.2	0.0	0.3	9.1	0.0	0.3	56.0	0.0	4.4	22.4	0.3	24.4	12.8	0.3	2.0	61.6	1.9	0.2	0.3	21.8	0.3	0.0	0.3	0.4	2.6	18.3	10.2	5.4	0.0	0.0	0.0	0.0	0.0	3.2	0.6	16.5	4.4	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.2	44.2	0.0	11.3	0.0	0.0	1.6	0.0	5.3	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.1	40.5	7.1	0.0	0.0	0.4	9.8	15.8	0.0	0.0	0.0	15.0	0.0	0.0	0.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.1	0.0	0.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.3	0.2	0.3	0.2	0.3	0.2	0.0	0.0	0.0	0.0	2.9	0.5	1.3	0.1	0.0	0.4	53.5	0.0	6.8	15.7	0.0	51.9	1.7	15.2	0.0	0.5	58.5	0.0	24.8	5.9	0.7	7.2	5.7	0.0	5.1	0.0	15.6	0.6	0.0	0.0	0.0	0.0	0.0	1.0	40.2	0.0	23.5	42.5	0.0	1.8	0.0	0.0	0.0	0.0	0.4	0.0	57.1	0.0	20.6	43.1
B3GNT4	"B3GN-T4, beta3Gn-T4"	ENSG00000176383	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4"	Q9C0J1	12	122203543-122208952	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 16.3;skin 1: 8.5"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 2: 2.6;Proximal tubular cells: 6.1;Spermatogonia: 2.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 8.2;hTCEpi: 9.9;T-47d: 7.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055261	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA055261: AB_2682765"	"unprognostic (1.67e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.82e-2)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (3.52e-6)"	"unprognostic (1.24e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.97e-2)"	"unprognostic (9.47e-2)"	0.7	3.2	7.3	0.8	6.8	4.6	0.8	16.3	9.1	0.5	0.7	0.5	0.0	1.0	0.6	0.7	1.8	1.1	1.1	0.8	4.9	4.0	6.1	0.6	1.1	0.9	1.5	7.3	0.8	0.8	0.8	1.9	0.8	4.0	0.7	0.6	1.0	1.7	0.7	1.1	8.5	1.0	0.6	0.6	1.0	0.7	2.0	0.3	0.0	0.8	0.3	0.8	0.6	0.5	0.8	1.0	0.8	1.7	0.4	1.9	0.4	5.5	1.0	0.4	2.2	0.2	0.1	1.0	0.1	0.0	0.3	0.7	3.5	0.5	0.5	1.0	0.0	0.4	2.0	2.7	2.2	0.2	8.2	2.8	0.2	1.5	0.3	0.6	0.7	1.1	0.7	9.9	0.1	0.5	0.8	0.0	2.0	1.6	0.7	0.2	4.9	0.0	0.7	0.6	0.2	2.0	0.4	0.6	1.0	1.4	0.6	1.4	1.8	1.6	1.0	0.5	0.9	7.6	0.1	0.1	0.5	2.8	0.5	0.3	0.6	5.0	1.2	0.5	0.8	0.3	0.8	0.4	0.2	0.8	0.1	0.4	0.8	1.3	0.2	0.2	0.5	1.9	0.2	0.5	0.4	1.7	1.0	0.6	0.4	7.3	6.8	16.3	8.1	4.9	4.0	1.5	7.3	4.0	0.3	0.0	2.6	0.0	0.7	1.1	0.1	0.4	0.0	1.4	1.2	0.0	0.0	0.4	1.7	1.0	0.2	0.0	0.0	0.0	0.2	0.4	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.6	0.6	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.4	0.6	0.0	6.1	0.1	0.0	0.2	0.5	2.6	1.3	0.5	0.5	0.3	0.4
B3GNT5	"B3GN-T5, beta3Gn-T5"	ENSG00000176597	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5"	Q9BYG0	3	183253244-183298504	"Enzymes, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 80.2"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 101.7;Syncytiotrophoblasts: 132.0;Urothelial cells: 125.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 9.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"GAMG: 30.4;HBEC3-KT: 25.2;hTCEpi: 30.7"	"Region enriched"	"Detected in single"	12	"cerebellum: 16.5"	"Low region specificity"	"Detected in all"			HPA017292	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA017292: AB_1845237"	"unprognostic (2.17e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (5.09e-4)"	"unprognostic (7.10e-3)"	"unprognostic (7.78e-2)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (7.23e-6)"	"unprognostic (4.20e-1)"	"prognostic unfavorable (1.30e-7)"	"unprognostic (1.18e-2)"	"unprognostic (2.71e-1)"	"unprognostic (3.53e-2)"	"unprognostic (8.10e-3)"	8.6	1.4	2.2	6.1	2.3	31.6	4.3	1.2	2.5	6.4	29.8	5.4	2.1	17.5	3.2	5.4	23.5	5.4	10.1	3.3	3.0	2.9	3.5	3.0	11.2	5.1	4.0	0.7	4.2	3.5	1.8	5.1	19.8	4.5	3.9	9.2	3.2	8.7	2.5	6.6	8.0	80.2	2.9	6.3	2.3	5.1	2.9	2.3	1.0	4.6	18.9	8.9	5.0	10.6	0.1	1.1	9.0	1.5	0.0	0.3	0.4	16.1	1.5	8.7	5.3	7.3	21.6	7.9	0.2	0.4	1.7	1.4	3.2	8.5	0.0	1.0	0.0	30.4	7.4	8.9	25.2	1.4	0.0	5.5	0.8	0.7	0.0	9.3	8.1	4.0	10.1	30.7	1.3	23.0	2.3	15.7	0.0	9.2	0.0	13.8	0.0	0.0	2.6	3.6	9.5	14.0	2.5	4.4	0.0	5.3	4.5	0.4	8.3	4.5	0.0	1.9	4.1	0.0	9.9	23.1	0.4	3.4	0.5	3.9	0.0	0.0	0.0	3.3	19.2	8.6	0.0	1.5	1.5	0.0	0.3	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.3	0.4	2.2	2.3	1.2	2.5	3.0	2.9	4.0	0.7	4.5	2.3	6.0	17.4	0.0	55.5	57.9	7.1	2.0	12.7	101.7	27.3	5.2	21.6	24.4	1.7	15.7	9.9	10.0	77.7	0.0	10.5	9.4	7.4	42.6	13.9	0.4	25.3	3.2	36.7	3.1	9.7	19.2	1.4	50.1	11.8	11.8	73.1	3.2	25.3	42.1	0.4	4.3	12.7	0.0	3.4	0.9	0.4	74.2	132.0	0.7	26.9	125.2
B4GALT1	"beta4Gal-T1, GGTB2"	ENSG00000086062	"Beta-1,4-galactosyltransferase 1"	P15291	9	33104082-33167356	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 56.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 56.9;SiHa: 107.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA010806, HPA010807"	Enhanced		Enhanced	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		98000000	"Golgi apparatus"		"HPA010806: AB_1078255, HPA010807: AB_1078254"	"unprognostic (7.57e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (6.85e-7)"	"unprognostic (1.83e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.78e-1)"	"unprognostic (7.93e-3)"	"unprognostic (4.98e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.46e-2)"	32.0	19.5	4.5	22.5	4.5	22.1	35.1	5.9	3.5	25.4	20.4	6.4	29.1	6.5	19.5	34.1	24.7	26.3	24.2	33.1	3.2	2.5	31.7	91.2	34.9	44.9	5.8	2.2	56.8	20.1	30.2	11.9	79.0	5.9	22.6	11.1	32.1	39.1	42.7	15.0	17.6	18.9	17.7	6.4	38.5	19.9	37.6	3.6	23.1	39.3	16.9	41.0	26.4	21.6	24.8	56.4	24.9	9.1	18.2	16.5	5.4	16.2	12.0	2.2	3.1	11.4	20.2	40.7	17.0	21.3	10.3	10.2	7.3	19.0	6.2	10.8	24.7	13.3	8.8	2.3	21.0	10.3	56.9	2.3	3.5	50.2	5.6	22.5	2.9	6.0	22.5	37.7	11.7	14.3	22.2	10.9	1.9	4.0	7.8	9.7	14.2	2.6	5.8	1.3	9.0	3.7	3.4	2.1	4.1	30.7	14.2	1.7	2.1	107.2	20.9	4.2	7.3	26.4	5.3	10.0	7.3	8.7	23.5	6.6	1.3	2.8	3.9	22.8	4.0	2.7	6.2	9.1	5.0	13.0	7.8	16.5	24.8	8.7	11.4	6.1	20.7	5.3	6.7	24.9	18.2	6.0	56.4	5.7	5.4	4.5	4.5	5.9	3.5	3.2	2.5	5.8	2.2	5.9	3.6	80.4	65.7	101.3	48.3	125.9	1.4	29.7	86.6	26.8	59.1	158.7	19.6	74.7	13.3	63.1	9.2	49.6	45.8	23.3	110.1	134.4	71.0	89.2	36.8	170.8	48.5	0.0	8.1	90.9	71.6	5.1	46.9	58.9	91.1	22.6	42.2	7.2	120.8	32.3	41.8	46.1	39.5	51.8	65.3	4.8	13.4	94.7	145.4	44.5	21.7	74.5
B4GALT2	beta4Gal-T2	ENSG00000117411	"Beta-1,4-galactosyltransferase 2"	O60909	1	43978943-43991170	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007620, HPA047739"	Supported		Supported	"Golgi apparatus,Vesicles"		NA	NA		12000	"Golgi apparatus, Vesicles"		"HPA007620: AB_2667879, HPA047739: AB_2680141"	"unprognostic (1.11e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (2.96e-5)"	"unprognostic (1.12e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.23e-3)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (3.62e-5)"	"unprognostic (6.54e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.12e-3)"	18.6	8.6	34.5	10.1	22.4	4.6	15.6	8.1	35.7	18.4	16.1	16.1	10.7	9.4	13.3	8.5	20.2	11.4	11.9	23.3	25.3	18.9	8.4	24.2	7.7	4.4	18.9	15.6	15.3	39.5	9.9	10.6	9.9	12.7	13.5	10.4	8.7	21.4	21.5	41.0	19.5	9.4	21.3	16.1	5.2	11.2	11.4	11.3	1.9	9.0	12.1	10.1	16.5	11.7	1.7	0.4	0.1	0.6	0.2	2.6	0.7	20.1	14.7	15.3	26.1	20.9	18.7	15.4	22.8	18.8	18.2	16.7	9.7	17.7	13.2	11.7	36.4	16.7	14.0	13.7	23.3	8.5	13.3	26.0	8.8	10.2	22.1	16.9	8.4	0.3	16.3	27.3	13.0	26.7	19.2	21.0	5.3	16.6	8.6	14.2	14.5	4.4	8.4	21.4	14.4	18.4	15.7	20.6	20.7	12.9	9.4	27.9	23.2	10.0	31.6	15.3	8.0	13.7	10.0	16.5	31.7	40.6	21.9	25.4	3.1	6.0	5.6	14.2	6.4	21.1	0.0	0.2	0.0	2.6	0.6	2.4	1.7	1.2	2.2	0.4	0.5	0.0	2.0	0.1	0.2	0.1	0.2	1.1	0.7	34.5	22.4	8.1	35.7	25.3	18.9	18.9	15.6	12.7	11.3	0.0	12.0	0.8	8.4	6.9	13.5	12.2	7.6	2.7	4.5	14.0	3.9	1.6	1.7	12.6	14.0	7.4	5.8	0.0	17.4	6.6	10.6	10.5	0.0	17.8	2.1	17.5	15.6	4.3	0.6	5.4	15.3	1.8	3.3	2.8	19.7	7.5	21.8	7.0	11.7	8.6	12.0	6.5	6.1	3.5	13.0	11.0	0.5	1.3	13.3	14.9
B4GALT3	beta4Gal-T3	ENSG00000158850	"Beta-1,4-galactosyltransferase 3"	O60512	1	161171310-161177968	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 95.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 74.9"	"Low region specificity"	"Detected in all"							HPA010793	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA		74000	"Golgi apparatus"	Cytosol	"HPA010793: AB_1078256"	"unprognostic (5.67e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.20e-2)"	"unprognostic (8.15e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (5.87e-5)"	"unprognostic (3.11e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (7.12e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-1)"	20.7	18.7	16.5	17.2	22.1	17.3	33.4	20.1	23.2	15.0	19.0	12.4	22.2	18.4	13.6	21.0	20.4	17.2	17.5	17.2	13.4	14.7	22.5	21.7	20.8	21.6	16.4	13.4	25.4	37.5	15.8	29.1	41.0	16.6	18.5	19.3	14.8	33.0	27.8	19.5	20.2	15.1	11.7	14.1	26.6	21.5	28.4	16.4	14.8	28.2	10.7	21.4	20.6	22.9	16.7	22.6	7.1	12.6	15.1	25.5	11.9	9.9	6.6	9.8	12.9	14.6	7.5	15.7	5.7	10.2	11.8	10.9	13.0	20.4	9.2	16.3	6.4	11.3	10.2	10.3	6.3	7.0	9.6	12.6	5.3	4.4	10.4	10.5	10.3	14.8	10.4	9.4	10.9	11.9	14.2	13.4	12.1	17.0	20.8	9.6	10.3	6.7	9.9	12.3	20.1	14.1	8.2	5.5	22.7	10.1	6.2	14.0	16.6	5.7	15.1	11.9	13.9	15.1	18.9	5.6	5.9	10.7	6.7	16.6	74.9	40.4	12.3	8.8	8.9	9.4	5.1	8.9	7.1	17.6	10.1	15.7	16.7	16.7	16.8	10.8	13.5	16.4	15.4	5.9	15.1	12.6	22.6	25.5	11.9	16.5	22.1	20.1	23.2	13.4	14.7	16.4	13.4	16.6	16.4	17.9	18.3	36.5	26.3	34.2	12.6	9.5	7.6	10.7	6.8	24.4	2.0	38.4	5.0	25.4	7.0	20.2	14.7	0.0	19.9	75.2	19.5	33.5	9.2	11.6	25.2	25.4	27.6	26.4	16.8	4.0	8.9	13.8	21.9	6.4	22.4	7.4	28.1	14.4	6.7	17.3	6.3	25.8	34.6	9.8	42.9	36.6	95.5	34.6	21.7	45.5
B4GALT4	beta4Gal-T4	ENSG00000121578	"Beta-1,4-galactosyltransferase 4"	O60513	3	119211732-119241103	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 111.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 38.8"	"Low region specificity"	"Detected in all"							"HPA046819, HPA063546"	Approved		Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"HPA046819: AB_2679824, HPA063546: AB_2685036"	"unprognostic (4.07e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.59e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (6.30e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.58e-1)"	"unprognostic (6.10e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.11e-1)"	9.6	7.7	7.0	8.6	8.5	11.6	8.8	5.3	6.6	10.1	20.8	8.2	12.6	14.6	15.1	43.4	13.2	12.6	21.3	11.1	6.0	6.2	15.0	11.8	8.9	8.0	7.7	7.3	13.5	20.8	8.5	16.2	23.7	9.1	9.4	17.9	10.2	10.1	16.1	4.8	10.9	40.4	11.3	9.3	8.2	16.8	5.8	6.5	8.5	10.8	6.5	11.4	13.0	8.7	3.7	4.7	11.2	4.6	11.7	12.2	4.8	17.6	34.3	4.0	2.8	12.5	10.4	20.4	38.8	17.2	18.1	18.2	20.2	5.7	3.8	8.1	20.3	10.9	24.3	6.8	5.2	18.3	7.5	2.3	5.2	5.8	10.7	8.6	3.1	4.7	7.5	7.3	7.7	6.2	6.9	1.7	2.8	3.6	4.0	7.4	6.7	1.4	2.7	5.2	10.2	9.3	1.4	3.7	1.5	9.9	19.4	3.5	8.2	9.3	4.1	8.4	9.0	8.9	1.4	1.2	8.6	7.9	4.3	4.3	8.9	7.0	5.0	7.2	2.9	7.1	11.2	3.7	6.8	12.2	4.6	6.9	3.7	6.0	6.4	4.7	2.9	11.3	6.8	2.2	11.7	4.0	3.1	2.3	4.8	7.0	8.5	5.3	6.6	6.0	6.2	7.7	7.3	9.1	6.5	0.0	6.5	17.8	18.3	9.5	10.5	7.7	40.8	30.8	18.2	7.0	3.9	30.1	1.7	26.8	0.9	8.3	39.8	0.0	29.7	111.2	24.4	21.4	12.7	9.0	12.7	17.5	13.3	4.3	7.5	1.7	13.8	10.8	13.5	13.6	76.6	21.5	28.0	42.1	26.5	21.6	9.4	19.4	12.7	1.6	10.5	9.3	43.7	14.6	21.7	68.6
B4GAT1	"B3GN-T1, B3GNT1, B3GNT6, BETA3GNTI, iGAT, iGNT"	ENSG00000174684	"Beta-1,4-glucuronyltransferase 1"	O43505	11	66345372-66347692	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 69.5"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 71.1;Horizontal cells: 149.4;Muller glia cells: 83.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015484	Uncertain				"Intracellular and membrane"	NA	NA		48000000			"HPA015484: AB_1845235"	"unprognostic (1.80e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.43e-3)"	"prognostic favorable (3.55e-5)"	"unprognostic (2.20e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.76e-3)"	8.3	24.8	29.3	3.6	47.1	1.0	5.4	28.5	69.5	7.8	6.5	11.8	4.2	9.5	10.0	9.5	5.2	10.5	6.0	19.6	33.3	57.9	15.0	9.7	9.7	3.7	24.7	32.0	18.9	12.8	11.9	15.6	12.9	31.0	10.2	4.9	10.1	9.1	14.2	12.9	5.8	7.2	8.5	13.2	5.1	7.7	4.4	11.6	1.1	10.7	1.7	2.8	5.5	4.1	5.6	6.8	0.4	1.1	3.9	9.7	4.2	4.0	10.2	11.7	14.2	13.1	11.9	15.5	7.1	16.5	11.1	9.1	7.6	5.8	3.3	30.2	6.5	9.5	6.5	12.4	7.9	5.4	6.6	22.6	0.5	8.4	29.1	7.8	2.6	1.0	11.5	6.1	6.9	2.9	36.8	13.0	5.7	3.1	5.3	5.2	6.8	6.2	7.2	7.9	4.0	10.9	9.0	9.1	5.9	11.5	1.0	7.0	13.3	6.1	4.1	27.5	7.6	16.6	2.6	7.5	8.7	6.4	11.0	3.6	10.3	7.1	1.9	14.7	2.2	10.1	0.0	1.1	0.0	7.1	0.4	9.7	5.6	7.8	7.6	2.8	3.5	9.2	8.4	0.4	3.9	0.2	6.8	5.3	4.2	29.3	47.1	28.5	59.9	33.3	57.9	24.7	32.0	31.0	11.6	20.8	9.6	6.9	1.2	0.0	71.1	36.7	28.1	5.3	3.4	19.2	55.0	47.1	5.0	5.9	0.3	19.1	8.1	0.0	5.3	19.6	10.0	1.2	1.1	22.2	11.1	149.4	4.7	22.7	2.4	0.9	30.2	0.4	0.0	1.8	9.9	83.3	5.0	3.5	38.2	15.1	37.5	25.8	8.6	1.2	2.6	0.0	15.1	2.2	7.6	0.3
FUT1	"H, HSC"	ENSG00000174951	"Fucosyltransferase 1 (H blood group)"	P19526	19	48748011-48755390	"Blood group antigen proteins, Enzymes, Predicted membrane proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 19.5"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 5.1;Endothelial cells: 5.1;Ito cells: 8.6;Melanocytes: 5.0;Pancreatic endocrine cells: 4.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 8.2;HEL: 10.2;hTCEpi: 8.1;RT4: 9.8"	"Not detected"	"Not detected"													NA	NA						"unprognostic (2.90e-2)"	"unprognostic (3.09e-2)"	"unprognostic (8.05e-3)"	"unprognostic (4.65e-3)"	"unprognostic (2.92e-3)"	"unprognostic (8.73e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (3.99e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.67e-3)"	"unprognostic (3.98e-2)"	2.5	0.8	0.9	0.9	0.9	1.5	1.6	3.5	1.4	0.9	0.9	0.9	0.9	1.0	0.9	0.9	1.5	1.2	0.9	1.4	0.9	0.2	1.1	0.9	6.8	0.9	0.9	0.9	0.9	19.5	1.0	1.7	2.8	0.9	0.9	0.0	0.9	0.9	0.9	0.9	0.8	0.9	0.9	0.9	3.4	7.6	0.9	0.9	0.9	1.0	0.9	0.9	0.9	0.9	0.9	0.9	3.3	0.7	1.5	0.6	0.3	3.3	0.1	0.1	0.2	0.0	0.0	1.7	0.2	0.1	0.2	0.2	8.2	4.8	0.3	0.4	0.2	0.8	5.5	1.6	5.1	0.1	0.0	0.8	10.2	0.4	0.1	2.4	0.4	4.5	0.0	8.1	0.4	3.7	0.1	3.6	1.8	0.5	1.5	0.0	3.8	0.2	6.2	1.0	6.5	0.5	0.3	0.0	1.6	0.3	9.8	7.7	0.5	0.4	7.1	0.1	0.4	4.6	0.2	3.5	0.3	2.5	0.2	0.3	1.4	3.6	1.0	0.1	0.3	0.3	3.3	0.7	0.5	0.5	0.3	0.3	0.8	0.6	0.4	0.3	0.9	0.6	0.5	2.1	1.5	0.3	0.9	0.2	0.3	0.9	0.9	3.5	1.4	0.9	0.2	0.9	0.9	0.9	0.9	3.0	1.7	0.0	0.6	2.3	0.3	0.8	5.1	0.0	1.2	0.0	2.0	0.3	1.7	1.1	0.0	5.1	0.0	0.0	1.9	0.2	1.0	0.9	1.1	0.0	0.3	0.0	1.2	8.6	1.0	0.0	0.9	1.5	5.0	0.0	0.4	0.0	4.9	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.1	1.5	0.3	0.0	0.0	0.4
FUT2	"SE, Se2, SEC2, sej"	ENSG00000176920	"Fucosyltransferase 2"	Q10981	19	48695971-48705950	"Blood group antigen proteins, Enzymes, Predicted membrane proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.3;salivary gland: 58.1"	"Cell type enhanced"	"Detected in many"	12	"Cholangiocytes: 43.3;Enterocytes: 109.6;Exocrine glandular cells: 41.1;Mucus-secreting cells: 39.5;Paneth cells: 73.7;Undifferentiated cells: 44.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"cerebellum: 8.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 34.7;OE19: 38.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014402	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA014402: AB_1849194"	"unprognostic (2.95e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.80e-3)"	"unprognostic (4.63e-3)"	"unprognostic (2.63e-1)"	"prognostic favorable (5.83e-4)"	"unprognostic (6.30e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.44e-2)"	"unprognostic (7.89e-2)"	"unprognostic (5.11e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.87e-1)"	0.4	0.6	0.7	5.3	0.8	0.0	0.8	8.7	1.6	9.3	25.0	0.3	13.9	24.1	1.3	0.1	16.0	1.2	23.3	0.5	0.7	0.7	0.8	0.4	1.1	0.1	0.7	0.1	1.0	7.5	0.0	1.5	0.2	0.7	1.2	10.9	0.1	58.1	14.5	0.5	2.6	41.3	0.4	0.7	0.6	15.8	0.7	0.2	0.5	0.6	16.1	19.3	3.1	5.4	1.7	1.8	3.5	1.0	1.4	2.5	0.6	0.9	0.9	0.2	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	4.1	34.7	0.3	0.2	0.0	0.2	6.1	0.0	0.0	0.0	0.3	0.2	0.3	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.4	0.0	0.4	0.4	0.8	0.2	38.7	0.3	0.3	0.1	1.5	0.0	0.3	1.8	0.2	0.1	0.3	0.0	0.2	5.2	0.0	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.0	0.1	0.2	0.1	3.5	0.8	0.4	2.0	0.7	1.1	1.5	2.3	1.0	0.5	1.7	2.1	0.7	3.4	1.4	1.0	1.8	2.5	0.6	0.7	0.8	8.7	1.6	0.7	0.7	0.7	0.1	0.7	0.2	0.0	1.1	0.0	2.5	0.8	2.7	0.4	43.3	12.0	10.3	19.2	2.0	0.0	1.7	5.5	0.5	0.3	109.6	0.0	41.1	0.0	0.2	2.5	0.0	0.0	0.1	0.0	10.9	0.0	0.3	0.0	0.0	0.0	1.7	0.0	39.5	0.8	25.6	73.7	0.0	0.0	3.8	0.0	0.2	0.2	0.2	1.3	0.1	2.2	44.3	14.7
FUT3	"CD174, LE"	ENSG00000171124	"Fucosyltransferase 3 (Lewis blood group)"	P21217	19	5842888-5851474	"Blood group antigen proteins, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 53.6;intestine: 49.3;lymphoid tissue: 38.4"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 106.6;Mucus-secreting cells: 61.1;Paneth cells: 66.6;Undifferentiated cells: 39.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 41.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 29.9;hTCEpi: 4.7;OE19: 13.4;RH-30: 10.1;SK-BR-3: 4.8"									HPA046966	Supported					NA	NA					"HPA046966: AB_2679879"	"prognostic unfavorable (6.86e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.63e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.99e-1)"	"prognostic favorable (8.22e-7)"	"unprognostic (5.66e-3)"	"unprognostic (9.56e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.07e-1)"	0.2	0.1	0.2	14.5	0.2	0.0	0.4	0.2	0.2	10.9	40.4	0.2	32.5	18.8	0.4	0.5	53.6	0.7	21.5	0.1	0.2	0.2	3.8	0.9	5.1	0.1	0.2	0.1	0.5	4.7	0.0	0.3	0.6	0.1	1.0	18.1	0.2	27.5	31.6	0.1	1.0	49.3	1.0	0.2	0.1	8.1	1.3	0.1	0.3	0.1	14.9	38.4	2.9	16.1	0.2	1.6	0.8	0.6	0.0	0.5	0.0	29.9	0.0	0.1	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.4	0.0	0.0	1.3	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	4.7	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	13.4	0.0	0.0	10.1	1.0	0.0	0.5	0.0	0.1	0.0	4.8	0.1	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.8	0.0	0.0	1.6	0.5	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.0	4.5	0.0	1.8	0.0	1.4	0.3	12.7	2.7	2.3	0.0	0.0	0.0	0.0	33.7	4.3	0.0	106.6	0.0	12.8	0.1	0.0	0.5	9.2	0.2	0.0	0.0	13.2	0.0	0.0	5.5	0.0	0.0	0.0	0.0	61.1	1.4	29.6	66.6	0.0	12.0	32.6	0.0	0.1	0.0	0.2	0.0	0.2	0.0	39.4	16.0
FUT4	"CD15, ELFT, FCT3A, FUC-TIV"	ENSG00000196371	"Fucosyltransferase 4"	P22083	11	94543840-94549898	"Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"bone marrow: 71.3"	"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 20.4;Mucus-secreting cells: 20.8;Pancreatic endocrine cells: 18.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HL-60: 20.8;NB-4: 13.5;THP-1: 26.3;U-937: 18.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB000014, CAB016129"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"CAB000014: , CAB016129: AB_626918"	"unprognostic (6.36e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.70e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.46e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (3.64e-4)"	"unprognostic (7.26e-2)"	"unprognostic (4.14e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.08e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.10e-3)"	5.5	2.4	5.5	6.1	6.2	71.3	6.3	3.0	6.0	4.4	8.3	6.7	4.7	10.9	5.9	2.5	3.0	4.6	7.5	3.7	6.2	2.2	4.1	3.0	6.0	5.4	8.1	2.5	4.9	11.4	1.4	2.9	3.4	4.8	3.4	8.3	3.8	6.3	2.9	1.7	1.9	10.1	5.8	5.7	6.5	9.7	2.9	4.5	10.4	2.9	1.9	3.1	4.4	3.0	0.7	1.9	2.5	3.9	0.8	1.9	0.8	1.6	0.8	1.0	0.0	3.2	2.9	5.3	1.5	0.7	1.3	1.5	7.1	2.3	0.0	3.6	2.5	0.7	0.8	1.7	0.1	1.3	10.7	1.7	5.3	1.2	0.1	1.6	20.8	4.7	2.5	0.0	1.7	0.0	0.3	2.1	4.8	5.3	0.0	1.6	0.8	4.3	13.5	2.0	6.5	2.0	3.9	0.0	0.0	1.4	1.1	1.4	0.5	0.9	2.1	0.8	3.1	1.2	26.3	1.9	1.1	2.9	0.0	0.5	0.6	0.3	0.0	0.9	18.7	0.6	2.0	3.1	2.5	1.1	1.5	0.7	0.6	1.0	1.3	1.8	0.7	1.1	0.7	1.7	0.8	3.9	1.9	1.9	0.8	5.5	6.2	3.0	6.0	6.2	2.2	8.1	2.5	4.8	4.5	0.0	0.0	0.0	2.3	1.4	0.6	0.8	20.4	2.7	2.3	1.8	3.9	12.9	0.0	12.8	0.2	1.3	12.1	0.0	15.5	2.0	4.6	1.6	0.0	0.8	7.7	0.0	9.8	2.5	10.6	0.2	4.0	3.3	3.3	10.0	20.8	0.5	18.4	3.5	1.1	1.9	8.8	0.0	1.4	0.9	3.2	0.5	1.8	2.5	14.4	1.2
FUT5	FUC-TV	ENSG00000130383	"Fucosyltransferase 5"	Q11128	19	5865826-5870540	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 1.8;SH-SY5Y: 3.0;U-266/70: 1.7"									HPA046966	Uncertain					NA	NA					"HPA046966: AB_2679879"				"unprognostic (7.72e-2)"	"unprognostic (3.59e-1)"		"unprognostic (5.03e-2)"			"unprognostic (1.20e-1)"								0.2	0.1	1.0	0.1	0.5	3.6	0.1	0.0	0.4	0.1	0.1			0.1	0.1	0.1	0.5	0.3	0.3	1.1	0.4	0.3	0.2	1.1	0.1	0.2	0.9		0.2	0.5	0.1	0.3	0.1		0.1	0.1		0.4	0.1	1.2	0.5	0.1	0.1	0.8	0.2	0.1	1.6			0.1		0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.3	0.1	0.0	0.7	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0
FUT6	"FCT3A, FLJ40754, FT1A, FucT-VI"	ENSG00000156413	"Fucosyltransferase 6"	P51993	19	5830610-5839731	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.8;intestine: 44.4;lymphoid tissue: 33.9;salivary gland: 37.0"	"Cell type enhanced"	"Detected in some"	13	"Enterocytes: 54.8;Mucus-secreting cells: 33.5;Proximal tubular cells: 29.8;Undifferentiated cells: 19.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 3.7;neutrophil: 1.2;NK-cell: 2.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 3.7;NK-cells: 2.1"	"Group enriched"	"Detected in some"	5	"Hep G2: 14.9;RPMI-8226: 5.6"									"HPA043707, HPA046966"	Approved		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA043707: AB_2678628, HPA046966: AB_2679879"	"unprognostic (3.65e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-3)"	"unprognostic (6.35e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (8.02e-2)"	"unprognostic (6.68e-3)"	"unprognostic (4.01e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.94e-2)"	"prognostic favorable (3.17e-8)"	"unprognostic (1.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.27e-1)"	0.2	0.2	0.2	7.2	0.2	0.1	0.8	0.2	0.2	9.2	26.4	0.0	9.5	15.6	0.7	7.6	40.8	0.6	25.4	0.2	0.2	0.2	27.2	6.5	1.3	0.2	0.2	0.0	0.2	2.2	0.0	0.8	0.0	0.0	0.3	6.9	0.0	37.0	19.1	0.2	0.2	44.4	0.2	0.2	0.2	2.8	0.3	0.0	0.0	0.2	16.4	33.9	0.2	12.4	0.4	0.3	3.7	0.3	2.1	0.3	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.2	14.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	1.2	5.6	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.3	0.1	3.7	0.3	0.4	0.2	0.1	0.1	0.1	0.3	0.2	0.1	0.4	0.3	0.2	1.2	2.1	0.1	0.3	0.1	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.3	0.3	15.3	1.4	0.0	1.8	0.0	0.1	3.3	4.7	0.2	0.0	54.8	0.0	0.3	0.1	0.3	0.2	0.0	4.9	0.1	0.0	4.7	0.6	0.0	0.0	0.3	0.0	0.0	0.0	33.5	0.5	1.6	15.6	0.0	29.8	12.1	0.0	0.1	0.6	0.5	0.1	0.0	0.0	19.9	1.4
FUT7		ENSG00000180549	"Fucosyltransferase 7"	Q11130	9	137030174-137033010	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 40.4;lymphoid tissue: 10.5"	"Cell type enhanced"	"Detected in some"	24	"Kupffer cells: 7.0;monocytes: 19.8;T-cells: 5.7"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"cerebellum: 3.2"	"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 40.4"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"NB-4: 14.4;THP-1: 18.5;U-937: 10.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042780			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA042780: AB_2678162"	"unprognostic (1.33e-2)"	"unprognostic (4.20e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.39e-2)"	"unprognostic (5.42e-2)"	"unprognostic (5.01e-6)"	"unprognostic (2.50e-1)"	"unprognostic (2.35e-2)"	"unprognostic (6.75e-4)"	"unprognostic (4.68e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.69e-6)"	"unprognostic (3.99e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.75e-2)"	0.4	0.1	0.2	2.5	0.2	5.9	0.2	3.2	0.3	0.2	0.2	0.2	0.2	0.0	1.4	0.2	0.4	0.5	4.4	0.2	0.3	0.3	0.2	0.2	1.5	6.2	1.7	0.2	0.2	0.2	0.0	0.4	0.2	0.9	0.2	0.0	0.2	0.2	0.2	0.2	0.4	0.6	0.2	0.4	10.5	0.3	0.2	0.2	0.2	0.3	0.2	4.6	0.5	0.2	4.2	40.4	18.3	1.5	22.1	16.3	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.4	0.0	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.3	1.5	0.3	2.1	0.3	10.5	4.2	10.3	5.7	4.4	1.2	0.2	0.8	18.3	22.1	0.0	40.4	16.3	3.4	0.2	0.2	3.2	0.3	0.3	0.3	1.7	0.2	0.9	0.2	0.0	0.0	3.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	7.0	0.0	0.0	2.9	0.0	19.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	5.7	0.2	0.0
FUT9	Fuc-TIX	ENSG00000172461	"Fucosyltransferase 9"	Q9Y231	6	96015984-96215612	"Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 37.7;stomach 1: 35.4"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 2.9;Exocrine glandular cells: 1.6"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.5"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"MCF7: 4.2;OE19: 4.1;RT4: 9.5;SCLC-21H: 9.7;SK-BR-3: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070923			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			Nucleoplasm	"Microtubules, Cytokinetic bridge, Cytosol"	"HPA070923: AB_2686323"	"unprognostic (1.60e-1)"	"unprognostic (2.48e-1)"		"unprognostic (5.99e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.40e-1)"		"unprognostic (2.97e-1)"		"unprognostic (1.35e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.43e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.03e-2)"	1.1	1.7	18.5	1.1	22.5	1.1	1.9	37.7	28.6	1.1	1.1	10.7	0.0	4.1	1.4	1.2	1.1	1.4	1.1	1.1	20.0	6.2	1.2	1.1	1.1	1.1	10.2	24.0	1.1	8.0	1.1	0.9	1.7	13.8	1.5	1.2	0.0	1.1	1.5	1.2	1.1	1.1	1.1	10.2	1.1	35.4	1.1	16.5	0.0	1.2	0.0	1.1	2.2	0.4	0.3	0.2	1.5	0.1	0.2	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	2.1	4.1	0.0	0.0	0.0	0.0	0.0	9.5	9.7	0.2	0.0	5.5	0.0	0.2	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.8	0.2	0.0	0.2	0.0	0.0	18.5	22.5	37.7	28.6	20.0	6.2	10.2	24.0	13.8	16.5	0.0	0.0	0.0	0.6	0.0	2.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.6	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.1
GBGT1	"A3GALNT, FS, MGC44848, UDP-GalNAc"	ENSG00000148288	"Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (FORS blood group)"	Q8N5D6	9	133152948-133163945	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"granulocytes: 11.5;Hofbauer cells: 19.5;Kupffer cells: 23.4;Macrophages: 13.6;monocytes: 11.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 30.7;HMC-1: 28.7;HUVEC TERT2: 11.9;NB-4: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051298	Approved				"Intracellular and membrane"	NA	NA					"HPA051298: AB_2681428"	"unprognostic (4.63e-3)"	"unprognostic (8.03e-2)"	"prognostic unfavorable (6.22e-4)"	"unprognostic (2.70e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.38e-1)"	"unprognostic (2.97e-2)"	"unprognostic (7.43e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.27e-3)"	"unprognostic (2.35e-1)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (3.46e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.35e-2)"	10.2	12.9	6.7	13.7	5.7	10.3	15.5	8.1	7.8	5.8	5.6	6.3	4.7	4.1	8.5	5.7	6.7	7.8	9.0	7.2	7.0	4.6	7.7	2.0	11.2	20.4	6.7	4.3	15.8	4.4	5.6	5.6	19.7	8.8	8.4	3.9	16.7	6.3	8.2	2.9	4.2	7.3	8.2	7.2	11.2	21.7	4.3	5.7	1.7	8.1	3.2	11.5	8.3	9.0	3.4	3.2	5.2	11.2	0.9	0.5	2.5	0.0	0.8	0.8	0.0	0.5	0.6	0.2	2.3	1.8	1.3	0.0	0.0	0.4	0.6	7.8	2.3	0.9	8.6	5.1	0.5	0.0	0.0	0.2	30.7	0.5	0.0	6.3	1.1	28.7	2.7	0.8	0.3	0.0	5.4	11.9	0.4	8.9	0.1	0.4	0.1	0.1	13.8	2.5	0.2	0.2	2.2	0.2	0.8	0.8	0.1	0.2	0.9	0.0	1.2	0.0	1.0	0.0	6.8	7.4	0.0	1.0	0.9	0.0	0.0	0.0	0.0	0.1	4.9	0.4	4.7	11.2	5.2	0.2	7.7	0.5	1.7	0.4	0.0	3.2	3.4	0.1	0.1	2.0	0.9	6.4	2.3	0.2	2.5	6.7	5.7	8.1	7.8	7.0	4.6	6.7	4.3	8.8	5.7	0.0	1.7	0.9	2.6	0.7	0.1	2.0	0.0	0.0	1.2	1.8	0.0	2.0	0.0	3.6	0.0	1.1	0.0	0.0	0.5	0.8	3.7	1.2	11.5	0.0	19.5	0.0	0.0	0.6	23.4	0.0	6.9	13.6	0.0	11.8	0.0	2.4	1.2	10.4	1.8	1.4	0.3	0.0	3.5	0.0	0.1	1.0	3.0	1.0	1.2	1.0
GCNT2	"bA360O19.2, bA421M1.1, CCAT, GCNT5, IGNT, II, NACGT1, NAGCT1, ULG3"	ENSG00000111846	"Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group)"	Q8N0V5	6	10492223-10629368	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.1"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 71.5;Melanocytes: 47.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 26.4;Hep G2: 11.0;SuSa: 10.2"	"Region enriched"	"Detected in many"	4	"basal ganglia: 54.8"	"Low region specificity"	"Detected in all"			HPA026776	Approved		Approved	"Golgi apparatus"		No	No		560000	"Golgi apparatus"		"HPA026776: AB_1849573"	"unprognostic (2.47e-1)"	"unprognostic (6.87e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.28e-4)"	"unprognostic (3.96e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.54e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-1)"	2.0	0.9	2.5	7.9	2.8	0.7	12.7	7.6	1.9	6.0	13.0	2.0	0.9	7.8	5.6	1.3	3.7	1.7	2.8	11.8	2.2	2.4	19.6	14.3	10.4	3.3	2.4	0.4	0.9	5.5	1.0	6.2	3.1	4.0	21.9	3.7	8.1	7.4	0.9	2.3	2.5	25.1	2.6	2.2	4.2	8.3	9.0	2.9	0.9	2.4	1.2	7.2	2.0	3.0	2.1	2.5	4.2	3.1	0.5	0.4	0.7	4.2	3.5	1.2	2.9	0.0	0.0	3.5	0.0	3.1	0.8	0.2	6.2	3.2	2.4	26.4	0.0	1.8	0.1	0.3	3.2	1.8	1.6	0.9	0.5	1.9	11.0	0.0	1.1	3.0	0.0	0.0	0.3	0.0	1.7	7.0	0.0	0.3	0.0	0.3	0.0	0.0	2.3	4.0	0.0	2.4	0.1	2.4	3.8	9.4	2.3	2.6	1.8	0.0	9.2	8.9	10.2	0.1	0.4	5.9	0.5	0.4	0.0	3.4	0.0	0.0	1.7	0.6	0.2	1.4	4.2	3.1	1.3	0.3	2.3	0.1	2.1	0.3	0.4	2.5	1.3	0.4	0.4	0.2	0.5	0.8	0.6	0.2	0.7	2.5	2.8	7.6	1.9	2.2	2.4	2.4	0.4	4.0	2.9	71.5	26.7	12.3	5.5	4.0	4.3	14.9	2.5	30.8	28.4	7.0	0.0	22.4	10.0	2.4	3.3	5.8	28.4	23.3	22.4	1.0	1.1	21.1	2.3	31.1	12.9	3.2	2.4	8.6	6.3	6.0	0.3	6.9	47.2	9.0	2.8	2.9	9.0	1.7	0.0	8.8	0.5	0.0	0.4	1.9	20.4	1.5	9.2	0.0	7.2	7.0
ST3GAL3	"MRT12, SIAT6"	ENSG00000126091	"ST3 beta-galactoside alpha-2,3-sialyltransferase 3"	Q11203	1	43705824-43931165	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 71.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051102	Uncertain				"Intracellular and membrane"	NA	NA					"HPA051102: AB_2681344"	"unprognostic (8.42e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.72e-2)"	"unprognostic (7.01e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.38e-3)"	"unprognostic (7.00e-2)"	"unprognostic (3.68e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.35e-1)"	"unprognostic (6.60e-2)"	11.6	9.0	13.0	8.9	16.5	9.9	12.8	15.5	20.4	9.0	10.3	9.0	8.0	3.2	10.8	10.7	8.7	8.3	7.2	16.9	12.8	13.9	6.7	9.1	7.2	7.6	12.0	10.4	13.3	7.5	6.9	10.9	6.7	11.6	8.8	5.1	9.0	8.0	13.9	71.5	7.4	3.8	15.9	7.7	6.0	5.9	14.5	10.3	3.2	8.1	17.8	4.8	8.1	7.0	7.1	7.0	5.8	4.2	4.7	7.6	6.1	2.4	1.9	14.2	6.7	11.2	14.2	1.8	9.3	19.4	8.7	8.4	1.6	4.0	4.5	4.8	11.9	4.8	2.3	1.2	6.1	10.5	5.3	3.2	8.6	6.0	4.6	9.4	3.9	4.3	7.5	4.6	6.4	14.0	16.7	6.8	11.2	5.1	8.4	16.1	1.6	4.0	7.4	5.6	0.6	5.0	6.7	1.9	3.0	7.0	1.6	5.8	8.5	3.7	1.4	8.1	6.0	2.1	18.8	6.5	5.2	2.4	8.5	9.4	6.7	3.8	4.2	7.7	9.4	9.6	2.9	4.2	2.5	6.8	2.5	6.1	4.5	4.4	5.1	3.0	7.1	7.6	5.7	5.8	4.7	3.7	7.0	5.2	6.1	13.0	16.5	15.5	20.4	12.8	13.9	12.0	10.4	11.6	10.3	6.0	20.0	0.9	2.8	3.0	8.5	22.8	2.5	6.7	3.4	3.5	0.0	2.1	5.0	2.6	16.4	7.4	0.2	0.0	2.1	1.2	7.4	2.0	23.1	9.0	2.6	17.5	2.4	4.3	2.4	10.2	3.4	4.6	3.3	3.6	1.2	3.9	2.3	0.0	11.0	5.6	16.1	19.4	7.2	5.2	3.8	1.1	0.8	3.5	1.6	7.9
ST3GAL4	"CGS23, FLJ11867, NANTA3, SAT3, SIAT4, SIAT4C, STZ"	ENSG00000110080	"ST3 beta-galactoside alpha-2,3-sialyltransferase 4"	Q11206	11	126355640-126440344	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 74.2"	"Cell type enriched"	"Detected in many"	9	"Syncytiotrophoblasts: 804.9"	"Cancer enhanced"	"Detected in all"		"melanoma: 57.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 31.3;neutrophil: 22.8;plasmacytoid DC: 29.6"	"Group enriched"	"Detected in many"	11	"dendritic cells: 29.6;granulocytes: 31.3"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 45.3;WM-115: 102.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA049827	Approved				"Intracellular and membrane"	NA	NA					"HPA049827: AB_2680900"	"unprognostic (8.89e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.93e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.90e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.16e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.36e-3)"	"unprognostic (8.78e-3)"	7.8	38.0	6.2	6.5	12.2	7.8	12.9	4.0	13.6	8.3	27.0	26.4	5.1	2.0	6.0	42.1	25.5	6.0	11.4	26.5	8.6	6.2	16.7	11.5	12.4	9.0	18.7	9.0	39.3	5.1	0.8	5.6	74.2	13.8	12.1	31.5	35.7	14.4	8.0	1.9	5.6	3.8	11.0	23.0	17.0	4.8	18.8	12.4	2.2	6.1	4.3	10.1	21.1	13.2	0.1	29.6	31.3	2.6	1.2	1.7	1.8	4.9	4.1	3.2	2.7	9.5	7.9	8.0	5.7	11.1	5.2	3.6	2.4	8.5	1.4	4.3	9.0	17.7	7.7	6.7	3.7	4.1	5.3	1.9	12.6	10.2	2.7	6.2	15.0	25.8	6.3	6.0	7.8	12.4	9.6	6.9	5.5	7.8	3.8	6.4	20.2	4.7	15.4	2.0	31.9	26.8	4.9	9.9	0.6	1.2	14.2	6.1	3.9	6.3	38.2	45.3	2.2	13.3	10.0	2.5	12.5	2.8	8.8	10.7	0.3	0.8	0.7	5.7	23.0	102.8	31.3	1.6	0.2	1.7	2.6	1.6	0.1	0.6	1.1	6.6	0.0	0.1	0.8	22.8	1.2	1.2	29.6	0.0	1.8	6.2	12.2	4.0	13.6	8.6	6.2	18.7	9.0	13.8	12.4	8.9	1.1	3.7	5.3	9.4	4.2	26.6	7.6	1.4	4.5	29.6	9.8	90.3	41.4	4.3	1.1	9.8	34.8	0.0	5.6	59.0	44.0	13.8	41.5	8.9	16.2	4.8	5.1	36.8	4.1	3.8	70.5	7.2	74.2	10.8	43.5	5.0	7.3	93.0	88.1	3.4	8.3	12.9	23.6	1.4	3.8	5.8	804.9	12.2	8.8	13.1
ST3GAL6	"SIAT10, ST3GALVI"	ENSG00000064225	"ST3 beta-galactoside alpha-2,3-sialyltransferase 6"	Q9Y274	3	98732236-98821201	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 46.7"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 61.5;Hepatocytes: 74.4;Melanocytes: 62.4"	"Cancer enhanced"	"Detected in many"		"melanoma: 17.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 20.7;neutrophil: 25.8"	"Group enriched"	"Detected in many"	144	"dendritic cells: 10.6;granulocytes: 25.8;monocytes: 7.7"	"Group enriched"	"Detected in many"	4	"RPMI-8226: 36.4;SK-MEL-30: 43.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018792	Approved					NA	NA		3000000			"HPA018792: AB_10964349"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.88e-3)"	"unprognostic (4.17e-2)"	"unprognostic (5.20e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.32e-1)"	"unprognostic (3.91e-3)"	"unprognostic (6.15e-3)"	"unprognostic (9.44e-2)"	"unprognostic (9.47e-3)"	"unprognostic (6.79e-4)"	11.5	7.5	5.9	3.6	8.3	2.4	6.0	14.4	8.2	4.9	3.6	6.7	1.9	2.2	2.4	11.3	2.4	6.0	2.4	21.8	7.1	5.9	12.2	46.7	7.1	3.5	9.5	4.3	1.7	4.7	1.1	4.6	20.1	10.1	3.5	3.0	6.3	15.9	2.3	6.5	14.4	2.2	2.3	17.4	3.0	4.6	1.8	7.4	14.3	3.1	2.2	2.8	1.6	1.9	0.0	10.6	25.8	7.7	0.0	0.1	1.8	0.1	0.5	0.8	1.1	1.3	0.4	5.0	0.1	0.6	0.5	0.9	3.3	0.2	2.4	1.3	0.0	1.8	0.8	1.5	0.8	0.4	0.0	1.0	0.1	0.2	5.9	5.8	5.0	9.5	0.6	0.0	1.4	2.7	9.1	5.7	1.0	0.0	2.5	0.5	0.0	0.8	8.6	1.4	0.0	1.4	0.4	0.6	36.4	1.3	0.0	1.5	7.8	2.0	0.2	43.1	1.5	0.1	9.0	4.2	1.1	0.9	0.3	0.4	9.7	0.7	0.0	1.9	7.2	4.0	7.4	7.7	20.7	0.0	4.1	0.0	0.0	0.0	0.0	10.6	0.0	0.1	0.0	25.8	0.0	2.0	2.4	0.0	1.8	5.9	8.3	14.4	8.2	7.1	5.9	9.5	4.3	10.1	7.4	11.9	35.7	2.2	2.8	10.2	1.0	33.9	5.1	32.1	1.2	3.5	7.9	36.5	11.6	4.9	0.2	13.4	0.0	0.0	1.8	61.5	2.2	4.8	36.0	74.4	33.3	0.0	15.4	33.2	23.8	0.2	2.6	39.4	62.4	44.1	0.0	0.6	4.2	0.0	6.3	9.0	2.6	6.5	2.0	0.0	0.4	11.2	22.5	0.0	0.0	0.9
ST8SIA1	"SIAT8, SIAT8A"	ENSG00000111728	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1"	Q92185	12	22063773-22437041	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.2"	"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 43.2;granulocytes: 32.4;Muller glia cells: 41.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"granulocytes: 1.2;T-cells: 3.0"	"Cell line enhanced"	"Detected in some"		"AF22: 9.1;ASC TERT1: 6.0;hTERT-RPE1: 4.2;RPTEC TERT1: 4.6;SK-MEL-30: 8.3;WM-115: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026775	Approved					NA	NA					"HPA026775: AB_1857534"	"unprognostic (1.98e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.79e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.37e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.07e-8)"	"unprognostic (1.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.16e-2)"	1.7	7.6	7.0	5.3	6.2	2.3	5.9	20.2	13.0	3.5	5.4	2.3	2.3	0.4	4.5	1.4	3.0	2.3	2.4	4.4	7.6	8.5	1.1	0.6	3.8	8.6	7.6	6.5	2.6	1.2	7.2	0.6	0.4	9.4	6.6	3.5	1.5	3.2	4.4	1.0	4.3	2.1	6.3	10.9	2.7	2.1	1.0	4.8	0.2	1.4	0.5	9.2	6.7	3.1	0.3	0.2	1.2	0.2	0.3	3.0	0.6	0.1	0.5	9.1	0.0	1.4	6.0	0.9	0.0	0.0	0.1	0.4	0.3	0.1	1.1	0.0	0.0	0.2	0.4	0.0	0.2	0.6	0.0	0.0	1.1	0.1	0.1	0.0	0.3	0.1	0.5	0.9	0.1	0.9	4.2	0.2	0.1	0.0	0.6	0.2	0.0	1.2	0.3	2.3	3.5	0.0	0.0	0.2	0.2	4.6	0.0	0.1	0.2	0.0	0.1	8.3	0.3	0.7	0.1	0.0	0.7	0.9	0.1	1.4	0.7	0.5	0.7	1.4	0.1	9.0	1.2	0.2	0.2	0.4	0.1	0.9	0.1	2.9	2.3	0.1	0.3	0.4	1.0	0.9	0.3	0.2	0.2	3.0	0.6	7.0	6.2	20.2	13.0	7.6	8.5	7.6	6.5	9.4	4.8	0.0	2.6	0.0	0.4	3.9	7.5	3.1	0.0	8.1	2.3	0.0	43.2	3.0	1.7	0.0	5.3	0.7	0.0	0.0	0.0	10.1	3.0	3.7	32.4	0.0	0.7	4.8	0.0	0.0	0.0	3.0	0.3	0.0	11.8	0.0	0.0	41.7	0.0	0.0	0.0	0.2	2.8	0.0	1.2	3.9	5.5	2.0	3.1	4.3	0.0	0.1
